UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q4 2019 | 2020-03-16 | 0.00 | 0.00 |
| Q3 2019 | 2019-11-14 | -1.35 | -1.35 |
| Q2 2019 | 2019-08-13 | -0.03 | -0.03 |
| Q1 2019 | 2019-05-13 | -0.22 | -0.22 |
| Q4 2018 | 2019-03-14 | 0.10 | 0.10 |
| Q3 2018 | 2018-11-14 | -0.55 | -0.55 |
| Q2 2018 | 2018-08-14 | -0.50 | -0.50 |
| Q1 2018 | 2018-05-15 | -0.70 | -0.70 |
| Q4 2017 | 2018-03-19 | -0.75 | -0.75 |
| Q3 2017 | 2017-11-09 | -0.85 | -0.85 |
| 2016-05-16 | Reiterated Rating | FBR & Co. | Buy | |
| 2016-05-16 | Reiterated Rating | FBR & Co | Buy | |
| 2016-03-17 | Boost Price Target | Rodman & Renshaw | Buy | $6.50 to $7.50 |
| 2016-03-17 | Lower Price Target | FBR & Co. | Outperform | $7.00 to $6.00 |
| 2016-03-03 | Initiated Coverage | FBR & Co. | Outperform | $7.00 |
| 2015-11-16 | Lower Price Target | Roth Capital | Neutral | $2.75 to $2.50 |
| 2015-11-12 | Initiated Coverage | HC Wainwright | Buy | $6.50 |
| 2015-10-29 | Lower Price Target | Roth Capital | Neutral | $4.50 to $2.75 |
| 2015-07-21 | Lower Price Target | Roth Capital | Neutral | $6.75 to $4.50 |
| 2011-10-03 | Downgrade | Maxim Group | Buy to Hold | |
| 1970-01-01 |
| 2016-05-16 | Reiterated Rating | FBR & Co. | Buy | |
| 2016-05-16 | Reiterated Rating | FBR & Co | Buy | |
| 2016-03-17 | Boost Price Target | Rodman & Renshaw | Buy | $6.50 to $7.50 |
| 2016-03-17 | Lower Price Target | FBR & Co. | Outperform | $7.00 to $6.00 |
| 2016-03-03 | Initiated Coverage | FBR & Co. | Outperform | $7.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CRMD 52 funds of 2186 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Inc. | 1.78M |
| Vanguard Group, Inc | 1.22M |
| BlackRock Institutional Trust Company, N.A. | 0.60M |
| STATE STREET CORP | 0.48M |
| GEODE CAPITAL MANAGEMENT, LLC | 0.36M |
| NORTHERN TRUST CORP | 0.33M |
| Nuveen Asset Management, LLC | 0.12M |
| BlackRock Fund Advisors | 0.11M |
| BRIDGEWAY CAPITAL MANAGEMENT INC | 98100 |
| Bank of New York Mellon Corp | 92193 |
| CITADEL ADVISORS LLC | 72789 |
| SCHWAB CHARLES INVESTMENT MANAGEMENT INC | 62952 |
| TWO SIGMA INVESTMENTS LLC | 54326 |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 52200 |
| Nine Chapters Capital Management LLC | 42400 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| PHARMABIO DEVELOPMENT INC | 3.54% (778563) | CRMD / |
| Gelbfish Gary A. | 3.13% (687927) | CRMD / |
| Khan Mehmood | 1.82% (400000) | CRMD / PEP / |
| Kaplan Myron | 1.34% (294166) | CRMD / |
| MILBY RANDY Chief Operating Officer | 1.12% (246243) | CRMD / |
| Lefkowitz Steven W | 0.99% (217399) | CRMD / |
| TELLEZ CORA M | 0.83% (182371) | CRMD / HMSY / PPBI / |
| ELLISON RUSSELL H | 0.73% (160000) | ASMB / CRMD / |
| Baluch Khoso Chief Executive Officer | 0.55% (121207) | CRMD / |
| Houser Mark T. Chief Medical Officer | 0.24% (52832) | CRMD / |
| Cook Robert W. Chief Financial Officer | 0.23% (50000) | CRMD / IMNP / MELA / |
| Lefkowitz James | 0.18% (40272) | CRMD / MNDL / |
| Dillione Janet | 0.18% (39969) | CRMD / NUAN / |
| ARMSTRONG JR. JOHN L. Exec VP of Tech Operations | 0.18% (38861) | CRMD / |
| Markvicka Taunia | 0.17% (37100) | CRMD / PCRX / |
| Duffy Matthew | 0.13% (28571) | CRMD / |
| Houghton John C. President and CEO | 0.08% (17328) | CRMD / |
| LENZ BRIAN Chief Financial Officer | 0.08% (17000) | ADMA / CRMD / |
| GEORGE MICHAEL W | 0.05% (10000) | CRMD / |
| HOFER TIMOTHY M Secretary | 0.04% (8425) | CRMD / |
Undercovermarket.com